Vascular endothelial growth factor serum concentrations in ovarian cancer

Obstetrics and Gynecology

Volumn 92, Issue 3, 1998, Pages 360-363

  Tempfer, Clemens ^a   Obermair, Andreas ^a   Hefler, Lukas ^a   Haeusler, Guenther ^a   Gitsch, Gerald ^a   Kainz, Christian ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; SURVIVAL TIME;

ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031657101     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00190-2     Document Type: Article

References (19)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat Med. 1:1995;27-31.
2. Battegay E.J. Angiogenesis mechanistic insights, neovascular diseases, and therapeutic prospects . J Mol Med. 73:1995;333-346.
3. Damert A., Ikeda E., Risau W. Activator protein 1 binding potentiates the hypoxia induced transcriptional activation of vascular endothelial growth factor expression in C6 glioma cells. Biochem J. 327:1997;419-423.
4. Neufeld G., Cohen T., Gitay-Goren H., Poltorak Z., Tessler S., Sharon R., et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev. 15:1996;153-158.
5. Borgstrom P., Hillan K.J., Sriramarao P., Ferrara N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody Novel concepts of angiostatic therapy from intravital videomicroscopy . Cancer Res. 56:1996;4032-4039.
6. Mu J., Abe Y., Tsutsui T., Yamamoto N., Tai X.G., Niwa O., et al. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. Jpn J Cancer Res. 87:1996;963-971.
7. Abu-Jawdeh G.M., Faix J.D., Niloff J., Tognazzi K., Manseau E., Dvorak H.F., et al. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest. 74:1996;1105-1115.
8. Nakanishi Y., Kodama J., Yoshinouchi M., Tokumo K., Kamimura S., Okuda H., et al. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol. 16:1997;256-262.
9. Obermair A., Bancher-Todesca D., Bilgi S., Kaider A., Kohlberger P., Mullauer-Ertl S., et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst. 89:1997;1212-1217.
10. Bancher-Todesca D., Obermair A., Bilgi S., Kohlberger P., Kainz C., Breitenecker G., et al. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol. 64:1997;496-500.
11. Salven P., Maenpaa H., Orpana A., Alitalo K., Joensuu H. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res. 3:1997;647-651.
12. Kang S.M., Maeda K., Chung Y.S., Onoda N., Ogawa Y., Takatsuka S., et al. Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma. Oncol Rep. 4:1997;381-387.
13. Moriyama M., Kumagai S., Kawashiri S., Kojima K., Kakihara K., Yamamoto E. Immunohistochemical study of tumor angiogenesis in oral squamous cell carcinoma. Oral Oncol. 33:1997;369-374.
14. Salven P., Heikkila P., Joensuu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer. 76:1997;930-934.
15. Paley P., Staskus K.A., Gebhard K., Mohanraj D., Twiggs L.B., Carson L.F., et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 80:1997;98-106.
16. Sobin L.H., Wittekind C. UICC TNM classification of malignant tumors. 5th ed. 1997;Wiley-Liss, New York, New York.
17. Obermair A., Kucera E., Mayerhofer K., Speiser P., Seifert M., Czerwenka K., et al. Vascular endothelial growth factor (VEGF) in human breast cancer Correlation with disease-free survival . Int J Cancer. 74:1997;455-458.
18. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
19. Yamamoto S., Konishi I., Mamdai M., Kuroda H., Komatsu T., Nanbu K., et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels . Br J Cancer. 76:1997;1221-1227.